Ahead of the Bell: St. Jude migraine implant

NEW YORK (AP) — St. Jude Medical Inc. may have difficulty getting its implantable migraine treatment approved after the device did not meet its main goal in a clinical trial, an analyst said Friday.

The St. Paul, Minn., company is studying neurostimulation therapy as a treatment for migraines. In that type of therapy, patients are implanted with a device that sends electrical pulses to electrodes in the brain. The devices are used to treat chronic pain.

St. Jude said Thursday that its Genesis neurostimulation device, which works on the occipital nerve, reduced pain and days with headaches. But similar numbers of Genesis patients and placebo patients reported a 50 percent decrease in pain.

Because the improvement was not statistically significant, the study did not meet its primary goal. St. Jude said significantly more Genesis patients did report at least a 40 percent reduction in pain.

The company enrolled 157 patients in the trial. On average, they had headaches 26 days per month. During the 12 weeks of the study, St. Jude said patients who received the Genesis implant had seven fewer headache days per month, compared to one less day for the placebo group.

Morgan Keegan analyst Jan Wald said Genesis can reduce headaches, but the Food and Drug Administration may not approve it because of the study failure. He said not all the patients were happy with Genesis: 24 percent of them said they would not get the implant again, and 12 percent either would not recommend it to others, or were not sure they would recommend it.

St. Jude said 51 percent of the Genesis patients were satisfied with their headache relief and 67 percent reported an improvement in quality of life. In the placebo group, 19 percent of patients were satisfied with their headache relief and 17 percent said they quality of life had improved.

Wald said St. Jude may have used too many surveys and created too many different measurements in order to prove the implant works, as studies of drugs and devices that treat pain can be subject to interpretation.

"These trials are notoriously hard to design, and it seems that St. Jude overreached when it should have played a more conservative game," he wrote. He kept an "Outperform" on St. Jude shares.

St. Jude Medical stock fell 2.6 percent to $47.40 on Thursday. The shares have traded between $34.25 and $54.18 in the last year.

  • Look, don't touch: Flickr photo of the day 1 hour 40 minutes ago
    Look, don't touch: Flickr photo of the day

    If there's one car that's particularly sought-after among today's well-heeled car collectors, a Ferrari 250 would be it. Usually it's the GTO variant, like the 1963 that sold for a record $52 million last year. A 250 of any sorts demands unfathomable cash, however, which is why we can but gawk at this 250 Testa Rossa. It's as close as any mere mortal will ever come to owning one.

  • Peeling out at Octane Academy, the free driving school for Ford ST owners 2 hours 36 minutes ago
    Peeling out at Octane Academy, the free driving school for Ford ST owners

    Buyers of Ferraris or Jaguars are used to perks from manufacturers – including racetrack lessons to help master their exotic machines. But for enthusiasts on a tighter budget, the Ford ST Octane Academy might be the sweetest deal in motoring: Buy a Ford Fiesta ST or Focus ST hatchback, and the reward is a free day of training at one of America’s longest, most-lavish road courses.

  • Why you can't buy America's greenest car 5 hours ago
    Why you can't buy America's greenest car

    Ask me or any auto expert what's the fastest car you can buy for any given amount, and we could easily cough up several options. Same for most luxurious, or off-roadable, or any other measurement. Yet there's one type of question that's far harder to answer: What's the greenest, most environmentally friendly car you can buy today?

  • Pirates kidnap three on Singapore tanker off Malaysia
    Pirates kidnap three on Singapore tanker off Malaysia

    Armed pirates boarded a Singapore-managed oil tanker in the Strait of Malacca, kidnapping three Indonesian crew and stealing some of the vessel's shipment of diesel fuel, the International Maritime Bureau said Wednesday. The attack occurred early Tuesday off Malaysia's west coast, said Noel Choong, head of IMB's Kuala Lumpur-based piracy reporting centre. The diesel oil tanker was believed to be en route to Myanmar. "IMB is aware of the attack on the Singapore-managed ship in the Malacca Straits.

  • McDonald's Hello Kitty sale site temporarily suspended due to fresh wave of Kitty mania
    McDonald's Hello Kitty sale site temporarily suspended due to fresh wave of Kitty mania

    It may not be safe to enter a McDonald’s restaurant in Singapore on Mondays starting 28 April. To celebrate the iconic Japanese character Hello Kitty’s 40th anniversary, the fast food chain announced last Friday that it would be releasing a new collection of Hello Kitty toys in McDonald’s restaurants island wide next Monday.

  • First sign of S.Korea ferry disaster was call from a frightened boy
    First sign of S.Korea ferry disaster was call from a frightened boy

    He called the emergency 119 number which put him through to the fire service, which in turn forwarded him to the coastguard two minutes later. That was followed by about 20 other calls from children on board the ship to the emergency number, a fire service officer told Reuters.